BACKGROUND: The chitinase-like protein YKL-40 is involved in inflammation and tissue remodeling. We recently showed that serum YKL-40 levels were elevated in patients with asthma and were correlated with severity, thickening of the subepithelial basement membrane, and pulmonary function. We hypothesized that single-nucleotide polymorphisms (SNPs) that affect YKL-40 levels also influence asthma status and lung function. METHODS: We carried out a genomewide association study of serum YKL-40 levels in a founder population of European descent, the Hutterites, and then tested for an association between an implicated SNP and asthma and lung function. One associated variant was genotyped in a birth cohort at high risk for asthma, in which YKL-40 levels were measured from birth through 5 years of age, and in two populations of unrelated case patients of European descent with asthma and controls. RESULTS: A promoter SNP (-131C-->G) in CHI3L1, the chitinase 3-like 1 gene encoding YKL-40, was associated with elevated serum YKL-40 levels (P=1.1 x 10(-13)), asthma (P=0.047), bronchial hyperresponsiveness (P=0.002), and measures of pulmonary function (P=0.046 to 0.002) in the Hutterites. The same SNP could be used to predict the presence of asthma in the two case-control populations (combined P=1.2 x 10(-5)) and serum YKL-40 levels at birth (in cord-blood specimens) through 5 years of age in the birth cohort (P=8.9 x 10(-3) to 2.5 x 10(-4)). CONCLUSIONS: CHI3L1 is a susceptibility gene for asthma, bronchial hyperresponsiveness, and reduced lung function, and elevated circulating YKL-40 levels are a biomarker for asthma and decline in lung function. Copyright 2008 Massachusetts Medical Society.
BACKGROUND: The chitinase-like protein YKL-40 is involved in inflammation and tissue remodeling. We recently showed that serum YKL-40 levels were elevated in patients with asthma and were correlated with severity, thickening of the subepithelial basement membrane, and pulmonary function. We hypothesized that single-nucleotide polymorphisms (SNPs) that affect YKL-40 levels also influence asthma status and lung function. METHODS: We carried out a genomewide association study of serum YKL-40 levels in a founder population of European descent, the Hutterites, and then tested for an association between an implicated SNP and asthma and lung function. One associated variant was genotyped in a birth cohort at high risk for asthma, in which YKL-40 levels were measured from birth through 5 years of age, and in two populations of unrelated case patients of European descent with asthma and controls. RESULTS: A promoter SNP (-131C-->G) in CHI3L1, the chitinase 3-like 1 gene encoding YKL-40, was associated with elevated serum YKL-40 levels (P=1.1 x 10(-13)), asthma (P=0.047), bronchial hyperresponsiveness (P=0.002), and measures of pulmonary function (P=0.046 to 0.002) in the Hutterites. The same SNP could be used to predict the presence of asthma in the two case-control populations (combined P=1.2 x 10(-5)) and serum YKL-40 levels at birth (in cord-blood specimens) through 5 years of age in the birth cohort (P=8.9 x 10(-3) to 2.5 x 10(-4)). CONCLUSIONS:CHI3L1 is a susceptibility gene for asthma, bronchial hyperresponsiveness, and reduced lung function, and elevated circulating YKL-40 levels are a biomarker for asthma and decline in lung function. Copyright 2008 Massachusetts Medical Society.
Authors: L A Lester; S S Rich; M N Blumenthal; A Togias; S Murphy; F Malveaux; M E Miller; G M Dunston; J Solway; R L Wolf; J M Samet; D G Marsh; D A Meyers; C Ober; E R Bleecker Journal: J Allergy Clin Immunol Date: 2001-09 Impact factor: 10.793
Authors: Zhou Zhu; Tao Zheng; Robert J Homer; Yoon-Keun Kim; Ning Yuan Chen; Lauren Cohn; Qutayba Hamid; Jack A Elias Journal: Science Date: 2004-06-11 Impact factor: 47.728
Authors: Susan M Varnum; Bobbie-Jo M Webb-Robertson; Joel G Pounds; Ronald J Moore; Richard D Smith; Charles W Frevert; Shawn J Skerrett; David Wunschel Journal: J Proteome Res Date: 2012-06-22 Impact factor: 4.466
Authors: Andrew T DeWan; Elizabeth W Triche; Xuming Xu; Ling-I Hsu; Connie Zhao; Kathleen Belanger; Karen Hellenbrand; Saffron A G Willis-Owen; Miriam Moffatt; William O C Cookson; Blanca E Himes; Scott T Weiss; W James Gauderman; James W Baurley; Frank Gilliland; Jemma B Wilk; George T O'Connor; David P Strachan; Josephine Hoh; Michael B Bracken Journal: J Allergy Clin Immunol Date: 2010-10 Impact factor: 10.793
Authors: Ann Chen Wu; Jessica Lasky-Su; Christine A Rogers; Barbara J Klanderman; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2010-06-10 Impact factor: 21.405
Authors: Taylor A Doherty; Naseem Khorram; Kotaro Sugimoto; Dean Sheppard; Peter Rosenthal; Jae Youn Cho; Alexa Pham; Marina Miller; Michael Croft; David H Broide Journal: J Immunol Date: 2012-02-10 Impact factor: 5.422
Authors: Dara G Torgerson; Daniel Capurso; Rasika A Mathias; Penelope E Graves; Ryan D Hernandez; Terri H Beaty; Eugene R Bleecker; Benjamin A Raby; Deborah A Meyers; Kathleen C Barnes; Scott T Weiss; Fernando D Martinez; Dan L Nicolae; Carole Ober Journal: Am J Hum Genet Date: 2012-02-10 Impact factor: 11.025
Authors: Jinyan Huang; Jun Chen; Jorge Esparza; Jun Ding; James T Elder; Goncalo R Abecasis; Young-Ae Lee; G Mark Lathrop; Miriam F Moffatt; William O C Cookson; Liming Liang Journal: Nat Commun Date: 2015-05-08 Impact factor: 14.919